Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China

Wednesday, September 30, 2020

CStone Pharmaceuticals and Pfizer Investment Co Ltd Pfizer Investment and Pfizer Corporation Hong Kong Limited announced the formation of a strategic collaboration that encompasses a million equity investment by Pfizer Hong Kong in CStone collaborat...

Orgenesis Announces Agreement to Acquire Koligo Therapeutics, a Leader in Personalized Cell Therapies

Wednesday, September 30, 2020

Orgenesis Inc a global biotech company working to unlock the full potential of cell and gene therapies and Koligo Therapeutics Inc Koligo a regenerative medicine company today announced that the two companies have entered into a definitive merger agr...

Vor Biopharma and Arbor Biotechnologies to Collaborate on Engineered Hematopoietic Stem-Cell Therapies

Tuesday, September 29, 2020

Vor Biopharma an oncology company pioneering engineered hematopoietic stem cells eHSCs for the treatment of cancer and Arbor Biotechnologies an earlystage life sciences company today announced an agreement to use Arbors gene editing technologies to e...

FibroGenesis Announces Manufacturing Agreement with iBiologics

Tuesday, September 29, 2020

FibroGenesis the leading developer of fibroblast based therapeutic solutions for unmet medical needs is pleased to announce it has entered into a manufacturing agreement with iBiologics to supply its proprietary allogeneic fibroblast cells to support...

AVROBIO Receives Orphan Drug Designation from the European Medicines Agency for AVR-RD-02, an Investigational Gene Therapy for Gaucher Disease

Monday, September 28, 2020

AVROBIO Inc a leading clinicalstage gene therapy company with a mission to free people from a lifetime of genetic disease announced that the European Commission EC has granted orphan drug designation for AVRRD the companys investigational gene therap...

Vivet Therapeutics and Pfizer Inc. Sign Agreement to Manufacture Investigational Gene Therapy Product Developed by Vivet for Wilson's Disease

Saturday, September 26, 2020

Vivet Therapeutics Vivet a privately held gene therapy biotechnology company dedicated to developing treatments for severe inherited liver diseases and Pfizer Inc announced that have signed a manufacturing agreement under which Pfizer will supply th...

Lumen Bioscience Awarded Federal Grant to Rapidly Develop Nanobody-based Covid-19 Therapeutic

Friday, September 25, 2020

Lumen Bioscience a clinicalstage biopharmaceutical company developing biologic drugs for highly prevalent diseases and the US Army Medical Research and Development Command USAMRDC operating through the Medical Technology Enterprise Consortium MTEC an...

AbCellera and IGM Biosciences Announce Multi-Year Antibody Discovery Collaboration

Friday, September 25, 2020

AbCellera and IGM Biosciences Inc announced today that they have entered into a multiyear multitarget strategic research collaboration and license agreement to facilitate the discovery and development of novel IgM antibodies

InSysBio announces its collaboration with Genmab

Thursday, September 24, 2020

InSysBio one of the worlds pioneers of Quantitative Systems Pharmacology QSP modeling announces its collaboration with Genmab an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics...

Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases

Thursday, September 24, 2020

Samsung Biologics and Kanaph Therapeutics have entered into a strategic partnership to develop KNP a bispecific Fc fusion protein intended to treat retinal diseases According to Kanaph Therapeutics KNP is designed to target autoimmune diseases by inh...

Latest Issue
Get instant
access to our latest e-book